IMGT (XKRX:456570) Stock Based Compensation : ₩462.46 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is IMGT Stock Based Compensation?

IMGT's Stock Based Compensation for the six months ended in Dec. 2023 was ₩462.46 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₩462.46 Mil.

IMGT Stock Based Compensation Historical Data

The historical data trend for IMGT's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Stock Based Compensation Chart

IMGT Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

196.92

401.39

402.43

462.46

IMGT Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Stock Based Compensation	196.92	401.39	402.43	462.46

IMGT Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₩462.46 Mil.

IMGT Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of IMGT's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT (XKRX:456570) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605

Website

http://www.imgt.co.kr

IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines